摘要
目的观察奥扎格雷钠联合低分子肝素钙治疗急性脑梗死的临床疗效。方法将92例住院急性脑梗死患者,分为两组进行治疗,对照组给予奥扎格雷钠注射液静脉滴注;治疗组在对照组基础上给予低分子肝素钙皮下注射。治疗结束后比较两组患者的临床疗效。结果治疗组总有效率为93.5%,对照组总有效率为80.4%,治疗组临床疗效明显高于对照组,二者相比具有显著性差异(P<0.05)。结论奥扎格雷钠联合低分子肝素钙治疗急性脑梗塞可明显提高临床疗效。
Objective To observe clinical effect of treating acute cerebral infarction with sodium ozagrel combined with low molecular weight heparin.Methods Totally 92 cases patients with acute cerebral infarction were randomly divided into two groups.The control group was treated by intravenous drip of ozagrel sodium injection,and the treatment group was treated by subcutaneous injection of azithromycin combined with chinese medicine based on the control group.The clinical effect was observed between control group and treatment group after treatment.Results The total effective rate of the treatment group and the control group was 93.5% and 80.4% respectively,the clinical effect in the treatment group was significantly higher than that of the control group(P〈0.05).Conclusions The sodium ozagrel combined with low molecular weight heparin on acute cerebral infarction can significantly improve clinical effect
出处
《医药论坛杂志》
2011年第9期37-38,40,共3页
Journal of Medical Forum
关键词
急性脑梗塞
奥扎格雷钠
低分子肝素钙
Acute cerebral infarction
Sodium ozagrel
Low molecular weight heparin